MYOKARDIA INC's ticker is MYOK and the CUSIP is 62857M105. A total of 157 filers reported holding MYOKARDIA INC in Q2 2019. The put-call ratio across all filers is 2.64 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $15,472,000 | +45.7% | 113,490 | +3.3% | 0.01% | +33.3% |
Q2 2020 | $10,618,000 | +166.2% | 109,890 | +29.1% | 0.01% | +125.0% |
Q1 2020 | $3,989,000 | -34.7% | 85,090 | +1.6% | 0.00% | -33.3% |
Q4 2019 | $6,107,000 | +42.1% | 83,790 | +1.7% | 0.01% | +20.0% |
Q3 2019 | $4,297,000 | +7.3% | 82,390 | +3.1% | 0.01% | +25.0% |
Q2 2019 | $4,006,000 | -1.6% | 79,890 | +2.0% | 0.00% | 0.0% |
Q1 2019 | $4,070,000 | +46.7% | 78,290 | +37.9% | 0.00% | 0.0% |
Q4 2018 | $2,775,000 | -22.6% | 56,790 | +3.3% | 0.00% | 0.0% |
Q3 2018 | $3,585,000 | +31.3% | 54,990 | 0.0% | 0.00% | +33.3% |
Q2 2018 | $2,730,000 | +50.8% | 54,990 | +48.3% | 0.00% | +50.0% |
Q1 2018 | $1,810,000 | +16.0% | 37,090 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $1,561,000 | -1.8% | 37,090 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $1,589,000 | +282.0% | 37,090 | +16.7% | 0.00% | – |
Q2 2017 | $416,000 | +24.9% | 31,790 | +25.7% | 0.00% | – |
Q1 2017 | $333,000 | +1.5% | 25,290 | 0.0% | 0.00% | -100.0% |
Q4 2016 | $328,000 | – | 25,290 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management III, LLC | 399,360 | $54,445,000 | 40.54% |
Copernicus Capital Management, LLC | 42,186 | $5,751,000 | 5.48% |
Casdin Capital, LLC | 870,000 | $118,607,000 | 5.31% |
Foresite Capital Management IV, LLC | 126,492 | $17,245,000 | 3.89% |
Avoro Capital Advisors LLC | 1,885,000 | $256,982,000 | 3.65% |
RTW INVESTMENTS, LP | 936,931 | $127,732,000 | 3.08% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 65,859 | $8,979,000 | 2.90% |
Perceptive Advisors | 1,395,017 | $190,183,000 | 2.78% |
Fernwood Investment Management, LLC | 38,547 | $5,255,000 | 2.48% |
Grace Capital | 23,400 | $3,190,000 | 2.47% |